HUTCHMED (China) Stock (NASDAQ: HCM) stock price, news, charts, stock research, profile.
Open | $21.600 |
Close | $21.750 |
Volume / Avg. | 316.285K / 137.802K |
Day Range | 21.550 - 21.920 |
52 Wk Range | 10.680 - 21.200 |
Market Cap | $3.713B |
P/E Ratio | 34.767 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 72 |
Short Interest | - |
Days to Cover | 4.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HUTCHMED (China) (NASDAQ: HCM) through any online brokerage.
Other companies in HUTCHMED (China)’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for HUTCHMED (China) (NASDAQ: HCM) was reported by Deutsche Bank on Friday, November 24, 2023. The analyst firm set a price target for 22.10 expecting HCM to rise to within 12 months (a possible 1.61% upside). 4 analyst firms have reported ratings in the last year.
The stock price for HUTCHMED (China) (NASDAQ: HCM) is $21.75 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for HUTCHMED (China).
HUTCHMED (China)’s H1 earnings are confirmed for Monday, July 29, 2024.
There is no upcoming split for HUTCHMED (China).
HUTCHMED (China) is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.